一、发展简史植入式心脏起搏系统于1958年在瑞典发明、至今已逾卅年。由于它在治疗与抢救某些心血管疾病(包括心率过缓、严重心律失常等)中效果异常显著、稳定和不可代替,目前全世界安装植入式起搏器的患者已超过百万。它不仅使患者康复,而且其中大部分还可重返工作岗位,从事力所能及的工作,因此受到医学与工程技术界的普遍重视。随着 First, a brief history of development Implantable cardiac pacing system invented in Sweden in 1958, has more than a year. Due to its remarkable, stable and irreplaceable effect in the treatment and rescue of certain cardiovascular diseases (including bradyarrhythmia, severe arrhythmia, etc.), there are now over one million patients worldwide with implanted pacemakers. It not only rehabilitated patients, but most of them were able to return to work and do whatever they could to get the job done. As a result, it has received universal attention from the medical and engineering communities. along with